Marketing-authorisation holder
YES Pharmaceutical Development Services GmbH
4 medicines in 3 countries, as authorisation holder.
Medicines
Every medicine in the registers under its name, current ones first.
4 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| MEVLYQSoluzione iniettabile | Eribulin | Italy | Authorised | |
| Mevlyq | Eribulin | EU (EMA) | Authorised | 2024 |
| Mevlyq 0,44 mg/ml oplossing voor injectieOplossing voor injectie | Eribulin | Netherlands | Authorised | 2024 |
| Lutholaz | Pegfilgrastim | EU (EMA) | Refused |
Countries
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| European Union (EMA) | 2 | 1 | 1 | CompaniesAll medicines |
| Italy | 1 | 1 | 0 | CompaniesAll medicines |
At a glance
- Type
- Marketing-authorisation holder
- Medicines
- 4
- Countries
- 3
- Roles
- Authorisation holder